03:25 AM EST, 12/17/2024 (MT Newswires) -- Hans Lennart Rudolf Wigzell, Director, on December 12, 2024, sold 10,500 shares in Sarepta Therapeutics ( SRPT ) for $1,310,820. Following the Form 4 filing with the SEC, Wigzell has control over a total of 22,840 shares of the company, with 22,840 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/873303/000095017024136847/xslF345X05/ownership.xml